Diabetes Care:1,5-脱水葡萄糖醇与亚临床心血管疾病有关

2016-10-25 xing.T MedSci原创

由此可见,在糖尿病患者中,1,5-AG与亚临床心血管疾病有关,尤其是慢性亚临床心肌损伤。然而,无论是观察到的关联是否与平均血糖无关还需进一步研究来证实。

1,5-脱水葡萄糖醇(1,5-AG)是葡萄糖峰的一种生物标志物,并已被证实与临床心血管疾病相关。然而,1,5-AG与亚临床心血管疾病之间的相关性尚未确定。近日,糖尿病领域权威杂志《Diabetes Care》发表研究文章,旨在探究1,5-AG与亚临床心肌损伤(通过测量高敏肌钙蛋白T [hs-cTnT]水平)和动脉粥样硬化(通过测量颈动脉内膜中层厚度[CIMT]和颈动脉斑块)的关系。

研究者共测定了10072例非糖尿病患者和681例糖尿病患者的1,5-AG、hs-cTnT、CIMT和颈动脉斑块情况。这些研究对象均来自1990年至1992年期间进行的社区动脉粥样硬化风险第二轮普查研究(ARIC)。研究者采用泊松回归模型来评估1,5-AG和升高的hs-cTnT、增厚的CIMT或颈动脉斑块的相关性。其中9145例研究对象在研究后6年进行第二轮hs-cTnT测量,研究者采用多元logistic回归评估hs-cTnT升高的相关因素。

通过分析,研究者发现相比于高水平的1,5-AG(≥10μg/mL)糖尿病患者,低水平的1,5-AG(<6μg/mL)与升高的hs-cTnT相关(患病率为2.06,95%可信区间为1.23–3.46)。而在未患糖尿病的患者中,低水平的1,5-AG与增厚的CIMT、颈动脉斑块之间的相关性并不强烈。糖尿病患者低水平的1,5-AG与研究6年后hs-cTnT的升高存在前瞻性的相关关系(相对危险度2.90,95%可信区间为1.23–6.85)。研究者还发现通过进一步调整糖化血红蛋白后,所有的相关的关联程度都有所减弱。

由此可见,在糖尿病患者中,1,5-AG与亚临床心血管疾病有关,尤其是慢性亚临床心肌损伤。然而,观察到的关联是否与平均血糖无关还需进一步研究来证实。

原始出处:

Menglu Liang,et al. Association of a Biomarker of Glucose Peaks, 1,5- Anhydroglucitol, With Subclinical Cardiovascular Disease. Diabetes Care. 2016 Oct; 39(10): 1752-1759.

本文系梅斯医学(MedSci)原创编译整理,转载需授权! 

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1797383, encodeId=df6a1e973831e, content=<a href='/topic/show?id=08a52280615' target=_blank style='color:#2F92EE;'>#临床心血管#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22806, encryptionId=08a52280615, topicName=临床心血管)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5a6b240, createdName=俅侠, createdTime=Fri May 05 17:14:00 CST 2017, time=2017-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759795, encodeId=d4751e5979576, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Sun Oct 08 05:14:00 CST 2017, time=2017-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1901483, encodeId=1781190148358, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Sat Jan 14 07:14:00 CST 2017, time=2017-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1637516, encodeId=3479163e5163f, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Tue Nov 29 09:14:00 CST 2016, time=2016-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1797390, encodeId=b0ce1e973901d, content=<a href='/topic/show?id=1f542280ec3' target=_blank style='color:#2F92EE;'>#临床心血管疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22807, encryptionId=1f542280ec3, topicName=临床心血管疾病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1c8c241, createdName=w363522449, createdTime=Sun May 07 18:14:00 CST 2017, time=2017-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1498074, encodeId=4cef14980e4b7, content=<a href='/topic/show?id=bb6f89e145a' target=_blank style='color:#2F92EE;'>#血管疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89714, encryptionId=bb6f89e145a, topicName=血管疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccb99370406, createdName=andy2090, createdTime=Thu Oct 27 03:14:00 CST 2016, time=2016-10-27, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1797383, encodeId=df6a1e973831e, content=<a href='/topic/show?id=08a52280615' target=_blank style='color:#2F92EE;'>#临床心血管#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22806, encryptionId=08a52280615, topicName=临床心血管)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5a6b240, createdName=俅侠, createdTime=Fri May 05 17:14:00 CST 2017, time=2017-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759795, encodeId=d4751e5979576, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Sun Oct 08 05:14:00 CST 2017, time=2017-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1901483, encodeId=1781190148358, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Sat Jan 14 07:14:00 CST 2017, time=2017-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1637516, encodeId=3479163e5163f, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Tue Nov 29 09:14:00 CST 2016, time=2016-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1797390, encodeId=b0ce1e973901d, content=<a href='/topic/show?id=1f542280ec3' target=_blank style='color:#2F92EE;'>#临床心血管疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22807, encryptionId=1f542280ec3, topicName=临床心血管疾病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1c8c241, createdName=w363522449, createdTime=Sun May 07 18:14:00 CST 2017, time=2017-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1498074, encodeId=4cef14980e4b7, content=<a href='/topic/show?id=bb6f89e145a' target=_blank style='color:#2F92EE;'>#血管疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89714, encryptionId=bb6f89e145a, topicName=血管疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccb99370406, createdName=andy2090, createdTime=Thu Oct 27 03:14:00 CST 2016, time=2016-10-27, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1797383, encodeId=df6a1e973831e, content=<a href='/topic/show?id=08a52280615' target=_blank style='color:#2F92EE;'>#临床心血管#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22806, encryptionId=08a52280615, topicName=临床心血管)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5a6b240, createdName=俅侠, createdTime=Fri May 05 17:14:00 CST 2017, time=2017-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759795, encodeId=d4751e5979576, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Sun Oct 08 05:14:00 CST 2017, time=2017-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1901483, encodeId=1781190148358, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Sat Jan 14 07:14:00 CST 2017, time=2017-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1637516, encodeId=3479163e5163f, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Tue Nov 29 09:14:00 CST 2016, time=2016-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1797390, encodeId=b0ce1e973901d, content=<a href='/topic/show?id=1f542280ec3' target=_blank style='color:#2F92EE;'>#临床心血管疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22807, encryptionId=1f542280ec3, topicName=临床心血管疾病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1c8c241, createdName=w363522449, createdTime=Sun May 07 18:14:00 CST 2017, time=2017-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1498074, encodeId=4cef14980e4b7, content=<a href='/topic/show?id=bb6f89e145a' target=_blank style='color:#2F92EE;'>#血管疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89714, encryptionId=bb6f89e145a, topicName=血管疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccb99370406, createdName=andy2090, createdTime=Thu Oct 27 03:14:00 CST 2016, time=2016-10-27, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1797383, encodeId=df6a1e973831e, content=<a href='/topic/show?id=08a52280615' target=_blank style='color:#2F92EE;'>#临床心血管#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22806, encryptionId=08a52280615, topicName=临床心血管)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5a6b240, createdName=俅侠, createdTime=Fri May 05 17:14:00 CST 2017, time=2017-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759795, encodeId=d4751e5979576, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Sun Oct 08 05:14:00 CST 2017, time=2017-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1901483, encodeId=1781190148358, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Sat Jan 14 07:14:00 CST 2017, time=2017-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1637516, encodeId=3479163e5163f, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Tue Nov 29 09:14:00 CST 2016, time=2016-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1797390, encodeId=b0ce1e973901d, content=<a href='/topic/show?id=1f542280ec3' target=_blank style='color:#2F92EE;'>#临床心血管疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22807, encryptionId=1f542280ec3, topicName=临床心血管疾病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1c8c241, createdName=w363522449, createdTime=Sun May 07 18:14:00 CST 2017, time=2017-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1498074, encodeId=4cef14980e4b7, content=<a href='/topic/show?id=bb6f89e145a' target=_blank style='color:#2F92EE;'>#血管疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89714, encryptionId=bb6f89e145a, topicName=血管疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccb99370406, createdName=andy2090, createdTime=Thu Oct 27 03:14:00 CST 2016, time=2016-10-27, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1797383, encodeId=df6a1e973831e, content=<a href='/topic/show?id=08a52280615' target=_blank style='color:#2F92EE;'>#临床心血管#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22806, encryptionId=08a52280615, topicName=临床心血管)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5a6b240, createdName=俅侠, createdTime=Fri May 05 17:14:00 CST 2017, time=2017-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759795, encodeId=d4751e5979576, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Sun Oct 08 05:14:00 CST 2017, time=2017-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1901483, encodeId=1781190148358, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Sat Jan 14 07:14:00 CST 2017, time=2017-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1637516, encodeId=3479163e5163f, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Tue Nov 29 09:14:00 CST 2016, time=2016-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1797390, encodeId=b0ce1e973901d, content=<a href='/topic/show?id=1f542280ec3' target=_blank style='color:#2F92EE;'>#临床心血管疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22807, encryptionId=1f542280ec3, topicName=临床心血管疾病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1c8c241, createdName=w363522449, createdTime=Sun May 07 18:14:00 CST 2017, time=2017-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1498074, encodeId=4cef14980e4b7, content=<a href='/topic/show?id=bb6f89e145a' target=_blank style='color:#2F92EE;'>#血管疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89714, encryptionId=bb6f89e145a, topicName=血管疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccb99370406, createdName=andy2090, createdTime=Thu Oct 27 03:14:00 CST 2016, time=2016-10-27, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1797383, encodeId=df6a1e973831e, content=<a href='/topic/show?id=08a52280615' target=_blank style='color:#2F92EE;'>#临床心血管#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22806, encryptionId=08a52280615, topicName=临床心血管)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5a6b240, createdName=俅侠, createdTime=Fri May 05 17:14:00 CST 2017, time=2017-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759795, encodeId=d4751e5979576, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Sun Oct 08 05:14:00 CST 2017, time=2017-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1901483, encodeId=1781190148358, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Sat Jan 14 07:14:00 CST 2017, time=2017-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1637516, encodeId=3479163e5163f, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Tue Nov 29 09:14:00 CST 2016, time=2016-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1797390, encodeId=b0ce1e973901d, content=<a href='/topic/show?id=1f542280ec3' target=_blank style='color:#2F92EE;'>#临床心血管疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22807, encryptionId=1f542280ec3, topicName=临床心血管疾病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1c8c241, createdName=w363522449, createdTime=Sun May 07 18:14:00 CST 2017, time=2017-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1498074, encodeId=4cef14980e4b7, content=<a href='/topic/show?id=bb6f89e145a' target=_blank style='color:#2F92EE;'>#血管疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89714, encryptionId=bb6f89e145a, topicName=血管疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccb99370406, createdName=andy2090, createdTime=Thu Oct 27 03:14:00 CST 2016, time=2016-10-27, status=1, ipAttribution=)]

相关资讯

Diabetes Care:达格列净或可有效缓解 1 型糖尿病

一项探索性试验研究提示,新型 2 型糖尿病治疗药物——达格列净(Farxiga,阿斯利康 / 百美施贵宝联合开发)或可作为 1 型糖尿病治疗的辅助用药。该研究是一项为期 2 周的随机、双盲、安慰剂对照、剂量范围研究,共纳入 62 例 1 型糖尿病患者。美国加州大学 

PLoS One:马普托的HIV- 1药物耐药的流行趋势

背景:一项在莫桑比克的马普托的观察性研究,探讨抗逆转录病毒(ART)天然抵抗受试者启动高效抗逆转录病毒疗法(HAART)艾滋病药物耐药(HIVDR)的流行趋势。方法/主要结果:评估抗逆转录病毒ART治疗失败后一线高效抗逆转录病毒疗法药物耐药性突变的模式(DRMs)[检测到病毒载量(VL)的患者]。招募了未经治疗的受试者(组1(G1;n = 99)]和274名以可变波长接触抗逆转录病毒ARV´s治疗

天猫医药馆、1号店纷纷收到暂停通知,医药B2C路在何方?

继天猫医药馆收到河北药监局暂停通知后,6月2日,1号店表示也收到了上海食品药品监督管理局转达的通知,即国家食品药品监督管理总局要求停止互联网第三平台药品网上零售试点工作,1号店表示最快在一周左右停止相关药品的销售。 据此前21世纪经济报援引消息人士,CFDA将相关通知分别下发到了河北药监局、上海药监局、广东药监局暂停第三方平台药品网上零售试点。目前,三家已经有两家公告声明确已经收到暂停通知

Diabetes Care:血糖峰值生物标志物1,5-AG与亚临床心血管疾病

背景:1,5-脱水葡萄糖醇(1,5-AG)是葡萄糖峰值的一种生物标志物,与临床心血管疾病相关。然而1,5-AG与亚临床心血管疾病之间的关联是未知的。我们研究了1,5-AG与亚临床心肌损伤(高敏肌钙蛋白T [ hs-cTnT ]评估)和亚临床动脉粥样硬化(由颈动脉内膜中层厚度[CIMT]和颈动脉斑块评估)之间的关系。方法:对10072非糖尿病患者和参加ARIC研究的681的糖尿病患者测定了1,5-A

ATV Biol:抑制Notch 1路径或可减小腹部主动脉瘤的恶化

2012年10月25日--10月18日,刊登在国际杂志Arteriosclerosis, Thrombosis,and Vascular Biology上的一篇研究报告中,来自国立儿童医院的研究者揭示了,一个跟癌症及心血管疾病相关的基因或许是引发主动脉瘤的一个诱因,当然其或许可以帮助研究者早日开发出主动脉瘤的新型疗法。这项研究首次揭示了Notch 1信号在小鼠和人类腹部主动脉瘤中是处于激